NCT02327195View on ClinicalTrials.gov

General Anesthesia Emergence Induced by Methylphenidate

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Delayed Emergence From Anesthesia
Interventions
DRUG

Methylphenidate HCl

Subjects will be randomly assigned to either the Methylphenidate or the Placebo arm, and be given a 20 mg dose (of Methylphenidate or Placebo) in liquid form (4 mL)

DRUG

Placebo

20 mg of placebo (PO) will be given 2 hours prior to surgery

Trial Locations (1)

43210

The Ohio State University Wexner Medical Center, Columbus

All Listed Sponsors
lead

Nicoleta Stoicea

OTHER

NCT02327195 - General Anesthesia Emergence Induced by Methylphenidate | Biotech Hunter | Biotech Hunter